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143.Microparticle subsets in patients with severe community-acquired pneumonia: association with outcome
H Lashin*, S Nadkarni*, J Knight §, M Perretti*, C Hinds* and the GAinS Investigators † *Barts and The London School of Medicine, London, UK. † University of Oxford, Oxford, UK Vesicles shed from the plasma membrane of activated cells, called microparticles (MP), are being investigated for their pathogenic role and for their potential as disease biomarkers. Identifying robust biomarkers in sepsis, to allow patient stratification and guide therapeutic interventions, is fundamental to improving outcomes. We have previously demonstrated that neutrophil-derived MP contain and express alpha-2-macroglobulin (A2M), 1 that numbers of A2M containing MP are significantly higher in survivors (S) than in non-survivors (NS) of severe sepsis 2 and that these MP have pro-resolving properties in experimental models of sepsis.
The aim was to study MP expressing A2M, their cells of origin and their relationship to outcome in a well-defined cohort of patients with severe sepsis secondary to community acquired pneumonia (CAP) during the first 24 hours of admission to ICU.
Patients were recruited to the UK Genomic Advances in Sepsis (GAinS) study. Plasma samples from selected cases were used for this study. MP were separated from plasma by using differential centrifugation. Flowcytometry was used to detect MP expressing Annexin V (AV) and A2M. Monoclonal antibodies were used to identify their cells of origin (granulocytes CD66b+, lymphocytes CD3+, erythrocytes CD235+ and platelets CD41+). Results are expressed as mean and standard error of the mean.
Sixty-one patients were studied with a median age (range) of 66(22-90) years, 25 were females. NS (n=31) were significantly older than S (n=30). Comorbidities were similar between both groups expect that significantly more S were reported as having asthma. There was no significant difference in granulocyte, lymphocyte, monocyte or platelet counts between NS and S. NS had a significantly higher admission SOFA score [median(range) 9(2-16), p=0.02] and APACHE II score [20(13-33), p=0.001] than S [6(2-17) and 16(7-24)] respectively. NS had a significantly lower AV+/A2M+ MP count (480±133/uL vs 1080±223/uL, p=0.03) and mean florescence intensity (1218±430 vs 2945±980, p=0.04) than S. In NS the AV+/A2M+/CD66b+ count was also significantly lower than in S (12±3 vs 50±17, p=0.04). In NS the AV+/A2M+/CD3+, AV+/A2M/CD235+ and AV+/A2M+/CD41+ counts were 67±16, 50±13, 154±43/uL respectively, while in the S the counts were 129±57), 64±21, 95±20/uL (none of these differences was significant) (Figure 1) . Higher AV+/A2M+ MP counts and MFI, as well as AV+/A2M/CD66b counts on Day 1 of ICU admission were associated with survival among patients with severe sepsis secondary to CAP. Mortality rates in sepsis progressively increase with the development of acute organ failure. Early interventions aimed at preventing organ failure are hampered by the lack of predictive accuracy of current methods of detecting early dysfunction. Most current markers only detect established organ failure. Sepsis has a profound impact on the metabolic processes necessary to maintain homeostasis and is associated with changes in the metabolic function of many organs. This work targets an unmet clinical need for new and refined diagnostics of acute organ failures by employing a top-down systems biology strategy to elucidate changes in hundreds of low molecular weight metabolites ("metabolic profiles") present in plasma by means of mass spectrometry. Serial plasma samples were collected from 50 patients recruited (mean age 59±14, M: F 27:23, APACHE II 21±7, 28-day mortality rate 28%), as part of the Vasopressin and Corticosteroids in Septic shock (VACS) randomised controlled trial. All patients received vasopressin therapy and then either steroids or placebo. Overall 154 blood samples were collected throughout time-point 0, days 1, 2 and 7, spun immediately and stored at -80°C until analysis. The metabolic profiles of samples were measured by ultra-performance liquid chromatography coupled to mass spectroscopy (UPLC-MS).
144.Exome sequencing reveals a novel putative risk mutation for meningococcal disease
Innovative Recursive Maximum Margin Criterion (RMMC) discriminant analysis was employed to recover metabolic patterns associated with dichotomised liver (SOFA) and kidney (AKIN) failure scores (normal vs any dysfunction). All models were 10-fold cross-validated. The receiver operating curve (ROC) analysis was used to assess the diagnostic capacity of multivariate models. The statistical relevance of individual metabolite intensities associated with organ dysfunction was evaluated by empirical Bayesian analysis of variance (ANOVA). The false discovery rate was controlled at a level of 0.05.
There were no significant differences in age, sex and number within each treatment arm between either of the pairs of organ failure groups. The prognostic models based on the differentiating metabolic patterns were associated with an overall classification accuracy of 86.4% (sensitivity of 86.5% and specificity 86.3%) and a predictive value of area under ROC (AUROC) of 0.9 for the presence of renal dysfunction. For liver dysfunction the classification accuracy was 90.9% (sensitivity 91.3% and specificity 90.3%) and the predictive value was These preliminary results demonstrated that predictive models based on metabolic profiling using UPLC-MS have the potential to identify patients with sepsis-related acute organ failures. Further work is required to identify if metabolic profiling can be used to identify the early onset of organ dysfunction before existing biomarkers. Achnowledgements The VACS trial was funded by the Intensive Care Foundation and the metabonomic analysis by the Imperial NIHR Biomedical Research Centre and Junior Research Fellowship scheme. Metabonomics compares and quantifies differences in metabolic profiles of biological fluids within disease states enabling hundreds of metabolites to be explored at one time. Our aim was to apply proton nuclear magnetic resonance ( 1 H NMR) spectrometry to serum samples obtained from ICU patients with and without pneumonia to determine if metabolic profiling has the potential to aid in the diagnosis.
146.NMR-based metabonomic analysis of serum
Patients admitted for invasive ventilation were recruited once consent was obtained from the next of kin, in accordance with ethics committee approval. Two groups of patients were enrolled; those that the treating consultant felt had pneumonia based on history, examination, and investigation results, and a control group made up of patients admitted with brain injuries with no evidence of pneumonia. Blood was collected within 48 hours of admission to ICU and the serum frozen at -80°C.
1D 1 H NMR spectra were obtained using a 600MHz Bruker spectrometer. After phasing, baseline correction and peak alignment of the spectra statistical comparison was performed using multivariate techniques including recursive maximum margin criterion discriminant analysis coupled with Mahalanobis-distance based classifier and subjected to tenfold cross validation. Individual spectral features were compared using empirical Bayesian analysis of variance (ANOVA).
Twenty-three patients were recruited (13 without and 10 patients with pneumonia). Mean age (51±18 yr vs 51±17 yr p=0.99), APACHE II score (19.4±5.3 vs 20.9±3.9 p=0.45), time to sampling (34.5±19h vs 44.7±13h p=0.14) and sex (69% vs 60% male p=0.69) were similar between groups. Discriminant analysis of the spectra provided a model with a classification accuracy of 83%. A model utilising only metabolites that reached a significance threshold of 0.05 or better on ANOVA improved classification accuracy to 87% and provided an area under the receiver operating curve (ROC) of 0.94. The majority of metabolites causing separation appear to be lipid species.
This preliminary investigation demonstrates that metabonomic techniques may be applied to the serum of critically ill patients with the potential to improve diagnostic accuracy of pneumonia. Applying similar methodology prospectively to patients requiring invasive ventilation may allow improvement in the diagnosis of ventilator associated pneumonia. Acknowledgements This project was funded by an Intensive Care Foundation Young Investigator award, the Imperial College NIHR Biomedical Research Centre and an Imperial College Junior research fellowship.
Gene expression signatures and regulatory variants in patients with severe sepsis due to community-acquired pneumonia: associations with outcome
EE Davenport*, J Radhakrishnan*, P Humburg*, TC Mills*, AC Gordon † , P Hutton ‡ , C Garrard ‡ , CJ Hinds § , JC Knight* and the GAinS Investigators *University of Oxford, Oxford, UK. † Imperial College, London, UK. ‡ John Radcliffe Hospital, Oxford, UK. § Barts and The London School of Medicine, London, UK Severe sepsis remains a major area of unmet clinical need with a mortality rate of over 30%. New insights into disease pathophysiology, as well as opportunities for early effective intervention and patient stratification are urgently required. The aim of this study was to identify differentially expressed genes and pathways associated with survival from severe sepsis. We also hypothesised that genetic modulators of gene expression might be specific to this disease context. We present data for a cohort of 240 patients of European ancestry with severe sepsis due to community-acquired pneumonia recruited to the Genomic Advances in Sepsis (GAinS) study. Phenotypic information, including survival up to 28 days after intensive care unit (ICU) admission was recorded using a web-based eCRF. Transcriptomic profiling was carried out for a total leukocyte cell population rapidly purified at the bedside using the Ambion LeukoLOCK Total RNA Isolation System. Gene expression was quantified from samples taken following admission to the ICU using Illumina HumanHT-12 v4 Expression BeadChip arrays for 47,000 probes. Genotyping was performed for 730,525 SNPs using the Illumina HumanOmniExpress BeadChip. Gene expression was mapped against genotype as a quantitative trait (eQTL). Following quality control, differential gene expression and eQTL analysis was carried out using 16,874 probes and 644,390 SNPs.
The cohort had a mean age of 62 years and 54% were male. The APACHE II score ranged from 6 to 35, with a median of 17, and the 28-day mortality rate was 21%. Five hundred and twenty-four probes (478 unique genes) were differentially expressed between survivors and non-survivors (false discovery rate <0.05). Ingenuity pathway analysis of these differentially expressed genes identified a number of pathways which are enriched within the data set, including iNOS signalling, assembly of RNA polymerase I complex and leucine degradation pathways. Expression of a number of genes in the iNOS pathway, for example IFNGR2 and IRAK2, are significantly down regulated in those who survive beyond 28 days. Of the differentially expressed probes, 162 associate with nearby genotyped SNPs that are within 1Mb of the probe and are probably cis-acting (false discovery rate <0.05).
This combined analysis of gene expression and genotype allows us to resolve the regulatory genetic variants that are important in the context of severe sepsis. Further, genetic signatures from transcriptomic profiling and eQTL analysis have the potential to improve patient stratification and inform early, targeted interventions. Acknowledgement This work was supported by the Wellcome Trust (grants 074318 JCK, 083712/Z/07/Z JR and 075491/Z/04 [core facilities Wellcome Trust Centre for Human Genetics]), the European Research Council (281824 JCK), the MRC (98082 JCK), the ICS, and the NIHR Oxford Biomedical Research Centre.
Staphylococcal toxins as a marker of
Staphylococcus aureus presence in intensive care patients Staphylococcus aureus (S.aureus) is a common bacteria which colonises the nasal mucosa; 1 its ability to colonise skin and mucosal surfaces means it is a significant pathogen in the intensive care unit (ICU). Detection of organisms using traditional microbiological methods is slow and insensitive when compared to newer methods of urinary antigen testing (UAT). 2 S.aureus produces a wide range of virulence factors, 3 the majority of which are eliminated by the kidneys; 4 these offer potential targets for UAT. However there is no published work available to indicate that these methods have been used to screen S.aureus in urine samples from adult patients.
Our aim was to demonstrate staphylococcal toxins in the urine of ICU patients, as a marker of S.aureus presence within the body.
We recruited 45 patients admitted to ICU at a district general hospital. Urine samples were obtained six-hourly over a 48-hour period. Two serum samples were also obtained and clinical data was recorded over the same period.
Using methods we adapted, urine samples were screened for the presence of four staphylococcal toxins (toxic shock syndrome toxin (TSST), staphylococcal enterotoxin B and C (SEB and SEC) and staphylococcal alpha haemolysin (AH) by Western Blot.
The majority of urine samples tested positive for AH (72%), while 5.9% were positive for TSST, 21% were positive for SEB and 7.5% were positive for SEC. We also tested serum samples for IgG antibodies towards the toxins. All patients had detectable levels of antibodies to AH, 72.5% had detectable anti-TSST IgG, 69% had detectable anti-SEB IgG, and 50% of participants had detectable anti-SEC IgG.
Five variables were significantly associated with increased risk of AH presence in urine, these were: increased serum creatinine, increased anti-AH IgG titre, abnormal white cell count, abnormal temperature and having an infectious diagnosis.
We present work that has developed methods for detecting potential markers of S.aureus in urine. Urine samples from patients in ICU show a high prevalence of staphylococcal toxins. Further work is required to determine the clinical significance, impact on practice and diagnostic use for these methods. Myocardial dysfunction in severe sepsis occurs early and frequently involves both ventricles. The relationship of dysfunction with mortality is unclear. 1 Two dimensional speckle tracking echocardiography has emerged as a method for quantifying myocardial deformation: strain and strain rate. 2 These parameters provide a sensitive method for assessment of systolic function: Left ventricle global longitudinal strain (LV GLS) and right ventricle (RV) free wall longitudinal strain. Longitudinal strain demonstrates contractile dysfunction not elicited by conventional methods of echocardiographic assessment 3 and aids prognostic value in diseases such as heart failure. 4 We sought to assess the degree of impairment of RV and LV longitudinal strain and whether myocardial dysfunction assessed by speckle tracking was associated with outcome. Sixty patients admitted to the intensive care unit with severe sepsis or septic shock received a transthoracic echocardiogram within 24 hours of meeting sepsis criteria. LV GLS and RV free wall longitudinal strain were analysed and compared to conventional systolic function assessment methods and to outcome at 30 days, six months and one year.
Thirty-three per cent of patients had LV dysfunction when assessed by ejection fraction compared to 69% having LV dysfunction based on LV GLS. Thirty-two per cent of patients had RV dysfunction based on conventional assessment compared to 72% assessed by RV free wall longitudinal strain. No statistical difference was observed between survivors and nonsurvivors at 30 days in any conventional or speckle tracking echocardiography method for left or right ventricle function. At 60 days only RV free wall longitudinal strain was associated with outcome (OR 1.13, 95%CI 1.02-1.26, p=0.02, AUC0.7). After adjustment, severe RV free wall strain impairment (less negative than -13%) remained associated with six-month mortality and was predictive of one year survival (p<0.0004). When assessed as a continuous variable, the unadjusted risk of death within one year increased 1.5 fold for every 5% decrease in RV free wall longitudinal strain (95%CI 1.0-25.2, p=0.034).
Speckle tracking echocardiography may unmask LV and RV systolic dysfunction not seen with conventional echocardiography in patients with severe sepsis or septic shock. LV dysfunction assessed either by conventional imaging or by LV GLS does not appear to correlate with early or late outcomes in sepsis. RV dysfunction assessed by free wall longitudinal strain does appear to be correlated with worse late outcomes, especially if the dysfunction is severe when assessed by strain. Severely reduced RV function assessed by free wall longitudinal strain is predictive for one-year mortality.
Our findings suggest that RV free wall longitudinal strain could potentially aid in prognosis in severe sepsis and has the potential to help guide therapy by emphasising the need to avoid possible mechanisms which may worsen RV function if severely reduced strain is identified.
